Allspring Global Investments’s Beam Therapeutics BEAM Stock Holding History

Allspring Global Investments’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$654K	Buy	19,535 +5,354	+38%	+$162K	﹤0.01%	1373
2026 Q1	$343K	Buy	+14,181	New	+$393K	﹤0.01%	1496
2023 Q3	–	Sell	-2,506	Closed	-$80K	–	2792
2023 Q2	$80K	Buy	2,506 +574	+30%	+$18.6K	﹤0.01%	2141
2023 Q1	$59.2K	Sell	1,932 -179	-8%	-$7.06K	﹤0.01%	2237
2022 Q4	$82.6K	Sell	2,111 -47	-2%	-$2.1K	﹤0.01%	2147
2022 Q3	$102K	Buy	2,158 +767	+55%	+$43.8K	﹤0.01%	2077
2022 Q2	$53K	Sell	1,391 -9,866	-88%	-$392K	﹤0.01%	2240
2022 Q1	$645K	Buy	11,257 +252	+2%	+$16.5K	﹤0.01%	2112
2021 Q4	$876K	Buy	+11,005	New	+$942K	﹤0.01%	2018

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Allspring Global Investments's BEAM Position: Q2 2026 in Review

Allspring Global Investments increased its Beam Therapeutics (BEAM) stake by 38% in Q2 2026, buying an estimated $162K and bringing the position to 19,535 shares worth $654K. The position accounts for ﹤0.01% of the portfolio, ranked #1373.

Allspring Global Investments first reported a position in BEAM in Q4 2021 and has held it in 9 quarters since. The position peaked at $876K in Q4 2021. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

Allspring Global Investments held 19,535 shares of Beam Therapeutics worth $654K as of Q2 2026.
Allspring Global Investments bought 5,354 Beam Therapeutics shares in Q2 2026, an estimated $162K.
Beam Therapeutics made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1373 holding.
Allspring Global Investments first reported a position in Beam Therapeutics in Q4 2021 and has held it in 9 quarters since.
Allspring Global Investments's Beam Therapeutics position peaked at $876K in Q4 2021.
277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.